Page 55 - Marcus News Today

Foreign television crew, is reason, or maybe excuse, for a big party, and preparations have already begun. maya slips seamlessly from her other life as a high fashion model back into a more traditional role in village life, working along with an army of other women to prepare what looks like a massive feast. how do they, uh, how do the ladies feel about you cooking, man? >> marcus: ah, this is, you see -- >> anthony: this is causing, uh, serious problems -- >> marcus: no, you already crossed it ...

All-Star candidate Marcus Stroman hopes to follow a Chicago Cubs loss with a win for the third consecutive time when he and his teammates open a three-game road

Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) have earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year target price […]

The Texas Rangers and St. Louis Cardinals are at the opposite ends of the success spectrum in June. The Rangers have opened the month with a five-game winning s

Motivation is there for city doing what united did in 99s— motivation is there for city doing what united did in 99s i think its all around the _ what united did in 99s i think its all around the club, _ what united did in 99s i think its all around the club, every - what united did in 99s i think its all around the club, every game, | all around the club, every game, i think you just look at competitions and pap audio and how serious he has taken them and i think is the standard that he sets....

The Marcus Corporation today announced that Gregory S. Marcus, chairman, president and chief executive officer, and Chad M. Paris, chief financial officer and treasurer, will participate in a... | May 31, 2023

Arcus Biosciences (NYSE:RCUS – Get Rating) had its target price hoisted by Citigroup from $40.00 to $41.00 in a research note published on Friday morning, The Fly reports. Several other research firms also recently weighed in on RCUS. Mizuho restated a buy rating and set a $51.00 price objective on shares of Arcus Biosciences in […]

The Marcus Co. (NYSE:MCS – Get Rating) announced a quarterly dividend on Tuesday, May 23rd, Wall Street Journal reports. Shareholders of record on Friday, June 2nd will be given a dividend of 0.05 per share on Thursday, June 15th. This represents a $0.20 annualized dividend and a yield of 1.29%. The ex-dividend date of this […]

Arcus Biosciences , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management... | May 30, 2023

AXQ Capital LP acquired a new position in Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 11,490 shares of the company’s stock, valued at approximately $238,000. A number of other hedge funds and other institutional investors […]